Abstract:Background: To explore the potential therapeutic effect of total flavonoids (TFs) extracted from Scabiosa comosa Fisch. ex Roem. et Schult on liver fibrosis in rat models and to identify the possible targets and pathways of TF in treating liver fibrosis by using a quantitative proteomics method. Methods: Sixty Wistar rats were equally randomized into five groups: a blank control group, a model group, and high-, intermediate-, and low-dose TF treatment groups. Except for the blank control group, rats in the other four groups were intragastrically administered with CCL4 2 mL/kg to establish the liver fibrosis models. Furthermore, the high-, intermediate-, and low-dose TF groups were intragastrically given TF at a dose of 200, 100 and 50 mg/kg, respectively. After 10 weeks, the rats were sacrificed, and blood and liver samples were collected. Serum alanine transaminase (ALT), Aspartate aminotransferase (AST), and alkaline phosphatase (ALP) levels were measured, and hematoxylin and eosin (HE) staining and Masson's trichrome staining were used to observe the pathological changes in each group. The hydroxyproline content was also determined. Real-time polymerase chain reaction (PCR) and Western blotting (WB) were performed to detect the mRNA and protein expressions of alpha-smooth muscle actin (aSMA) and Collagen I. Mass spectrometry was performed for proteomic analysis. Results: Compared with the blank control group, the model group had significantly higher ALT, AST, ALP, and hydroxyproline levels; also, HE and Masson staining showed fibrotic lesions and inflammatory cell infiltration in the model group. Compared with the model group, the high-, intermediate-, and lowdose TF groups had significantly decreased ALT, AST, and ALP levels (P<0.05), and a significantly lower hydroxyproline level (P<0.05), along with remarkably improved fibrotic lesions and inflammatory cell infiltration. Real-time PCR and WB showed that the model group had significantly higher expressions of aSMA and collagen I than those in the blank control group, whereas the TF groups had significantly lower expressions of aSMA and collagen I than those in the model group. A total of 5,014 proteins were detected by quantitative proteomics, among which 205 proteins were differentially expressed, 77 of which were upregulated and 128 of which were down-regulated. KEGG pathway analysis indicated that the peroxisome proliferator activated receptor (PPAR) and ECM-receptor interaction pathways were down-regulated in the TF groups compared with the model group. Among them, fatty-acid-binding protein (FABP) and von Willebrand factor (vWF) were the key proteins in the PPAR and extracellular matrix (ECM)-receptor interaction pathways. The proteomic results were validated by using WB, yielding consistent results. Conclusions: Our result demonstrated that the TF extract of Scabiosa comosa Fisch. ex Roem. et Schult has a good anti-liver fibrosis effect and may prevent liver fibrosis by reducing the content of alpha-SMA, Collagen. in liver tissue. The anti-fibrosis mechanism of TF extract of Scabiosa comosa Fisch. ex Roem. et Schult may be the inhibition of key proteins FABP and vWF in PPAR, ECM RECEPTOR INTERACTION pathway.

Role and mechanism of action of the Mongolian medicine Scabiosa atropurea in inhibiting the proliferation of hepatic stellate cells

Liver Fibrosis Therapy Based on Biomimetic Nanoparticles Which Deplete Activated Hepatic Stellate Cells.

Effects of total lignans from Tibetan medicine Herpetospermum pedunculosum seeds on proliferation and apoptosis of rat hepatic stellate cells

[To Explore Mechanism of Scabiosa Comosa Against Liver Fibrosis Based on Pharmacodynamics and Network Pharmacology].

Turtle Carapace Decoction and Drug Containing Serum on Hepatic Stellate Cells

18α-Glycyrrhizin induces apoptosis and suppresses activation of rat hepatic stellate cells.

Systematic profiling of the effective ingredients and mechanism of Scabiosa comosa and S. tschilliensis against hepatic fibrosis combined with network pharmacology

Anti-liver Fibrosis Effect of Total Flavonoids from Scabiosa Comosa Fisch. Ex Roem. Et Schult. on Liver Fibrosis in Rat Models and Its Proteomics Analysis

Effects of mogrosides on proliferation of hepatic stellate cell-T6 and hepatofibrosis-related gene

The effects of inhibiting the activation of hepatic stellate cells by lignan components from the fruits of Schisandra chinensis and the mechanism of schisanhenol

The Salvia Miltiorrhiza Monomer IH764-3 Induces Apoptosis of Hepatic Stellate Cells in Vivo in a Bile Duct Ligation-Induced Model of Liver Fibrosis.

San-Cao Granule (三草颗粒) Ameliorates Hepatic Fibrosis through High Mobility Group Box-1 Protein/Smad Signaling Pathway

18Α‐glycyrrhetinic Acid Extracted from Glycyrrhiza Radix Inhibits Proliferation and Promotes Apoptosis of the Hepatic Stellate Cell Line

Effects ofAralia on apoptosis and expression of apoptosis-related genes in hepatic stellate cells

Therapeutic effect and its mechanism of Haobie Yangyin Ruanjian Prescription on mice with liver fibrosis caused by schistosomiasis

Effects of all-trans retinioc acid on expressions of COL1α2,MMP-2,TIMP-1, and signaling pathway in TGF-β1-simulated rat hepatic stellate cells

Arctigenin induces activated HSCs quiescence via AMPK-PPARγ pathway to ameliorate liver fibrosis in mice

Schisandrin B Attenuates Hepatic Stellate Cell Activation and Promotes Apoptosis to Protect against Liver Fibrosis

Salvianolic acid A attenuates CCl4-induced liver fibrosis by regulating the PI3K/AKT/mTOR, Bcl-2/Bax and caspase-3/cleaved caspase-3 signaling pathways

Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells

Inhibitory Effects of Baicalin on Proliferation of Hepatic Stellate Cells and Synthesis of Extracellular Matrix